Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H E Spohn

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Abnormal Psychology|August 1, 1973
The case for reporting the drug status of patient subjects in experimental studies of schizophrenic psychopathologyH E Spohn
Psychopharmacologia|January 1, 1972
A strategy for the study of behavioral mechanisms of antipsychotic drug action in schizophreniaH E Spohn
Schizophrenia Bulletin|January 1, 1983
Is eye tracking dysfunction specific to schizophrenia?H E Spohn, J Larson
Schizophrenia Bulletin|January 1, 1979
Recent studies of psychophysiology in schizophreniaH E Spohn, T Patterson
Journal of Abnormal Psychology|February 1, 1980
Informed consent and bias in samples of schizophrenic subjects at risk for drug withdrawalH E Spohn, T Fitzpatrick
Schizophrenia Bulletin|January 1, 1982
Social dysfunction and treatment failure in schizophreniaC Schooler, H E Spohn
Brain and Cognition|September 1, 1993
The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenicsH E Spohn, L Coyne
The Journal of Nervous and Mental Disease|October 1, 1976
How long does chlorpromazine last?R B Lacoursiere, H E Spohn
Journal of Abnormal Psychology|November 1, 1989
Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophreniaH E Spohn, M E Strauss
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Topographic evoked potentials during backward masking in schizophrenics, patient controls and normal controlsT Patterson, H E Spohn, K Hayes
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Abnormal Psychology|August 1, 1973
The case for reporting the drug status of patient subjects in experimental studies of schizophrenic psychopathologyH E Spohn
Psychopharmacologia|January 1, 1972
A strategy for the study of behavioral mechanisms of antipsychotic drug action in schizophreniaH E Spohn
Schizophrenia Bulletin|January 1, 1983
Is eye tracking dysfunction specific to schizophrenia?H E Spohn, J Larson
Schizophrenia Bulletin|January 1, 1979
Recent studies of psychophysiology in schizophreniaH E Spohn, T Patterson
Journal of Abnormal Psychology|February 1, 1980
Informed consent and bias in samples of schizophrenic subjects at risk for drug withdrawalH E Spohn, T Fitzpatrick
Schizophrenia Bulletin|January 1, 1982
Social dysfunction and treatment failure in schizophreniaC Schooler, H E Spohn
Brain and Cognition|September 1, 1993
The effect of attention/information processing impairment of tardive dyskinesia and neuroleptics in chronic schizophrenicsH E Spohn, L Coyne
The Journal of Nervous and Mental Disease|October 1, 1976
How long does chlorpromazine last?R B Lacoursiere, H E Spohn
Journal of Abnormal Psychology|November 1, 1989
Relation of neuroleptic and anticholinergic medication to cognitive functions in schizophreniaH E Spohn, M E Strauss
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1987
Topographic evoked potentials during backward masking in schizophrenics, patient controls and normal controlsT Patterson, H E Spohn, K Hayes
Pageof 3